# Genetic Architecture of Natriuretic Peptides and Blood Pressure Response

> **NCT07118592** · NA · NOT_YET_RECRUITING · sponsor: **University of Alabama at Birmingham** · enrollment: 200 (estimated)

## Conditions studied

- Hypertension (HTN)
- Cardiometabolic Diseases

## Interventions

- **DIETARY_SUPPLEMENT:** Low Salt Diet
- **DIETARY_SUPPLEMENT:** High Salt Diet
- **DIETARY_SUPPLEMENT:** Saline Infusion

## Key facts

- **NCT ID:** NCT07118592
- **Lead sponsor:** University of Alabama at Birmingham
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-09-01
- **Primary completion:** 2030-06-01
- **Final completion:** 2030-12-01
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2026-03-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07118592

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07118592, "Genetic Architecture of Natriuretic Peptides and Blood Pressure Response". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT07118592. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
